Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1

Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1

A phase I/II trial of a candidate vaccine to prevent HIV infection was carried out in Bangkok, Thailand, testing AIDSVAX B/E (VaxGen, Inc., Brisbane, CA), a bivalent subunit vaccine prepared by combining recombinant gp120 from a subtype B virus (HIV-1MN) with gp120 from a subtype E virus (HIV-1A244)...

Full description

Saved in:
Bibliographic Details
Main Authors: Punnee Pitisuttithum, Phillip W. Berman, Benjaluck Phonrat, Pravan Suntharasamai, Suwanee Raktham, La Ong Srisuwanvilai, Krit Hirunras, Dwip Kitayaporn, Jaranit Kaewkangwal, Sricharoen Migasena, Haynes W. Sheppard, Elizabeth Li, Marlene Chernow, Michael L. Peterson, Riri Shibata, William L. Heyward, Donald P. Francis
Other Authors: Mahidol University
Format: Article
Published: 2018
Subjects:
Medicine
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/21578
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University

Similar Items

Similar Items